3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
2
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Nasopharyngeal Carcinoma
21
Prostatic Neoplasms
8
Breast Neoplasms
7
Head and Neck Neoplasms
6
Esophageal Squamous Cell Carcinoma
6
Esophageal Neoplasms
6
Rectal Neoplasms
4
Radiation Injuries
4
Carcinoma, Squamous Cell
4
Carcinoma, Non-Small-Cell Lung
4
Neoplasm Metastasis
3
Nasopharyngeal Neoplasms
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Salivary Gland Neoplasms
2
Recurrence
2
Lung Neoplasms
2
Vulvar Neoplasms
1
Thyroid Neoplasms
1
Sinonasal undifferentiated carcinoma
1
Radiation
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ototoxicity
1
Obesity
1
Neurotoxicity Syndromes
1
Neoplasms
1
Interventions
Tamoxifen
3
Neoadjuvant Therapy
2
Amplified Fragment Length Polymorphism Analysis
2
Ultrasonography
1
Saline Solution
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiation
1
Polymerase Chain Reaction
1
Pharmacogenomic Testing
1
Mammography
1
In Situ Hybridization, Fluorescence
1
Immunohistochemistry
1
Immunoenzyme Techniques
1
Fulvestrant
1
DNA Methylation
1
Chemotherapy, Adjuvant
1
Carboplatin
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Carcinoma, Intraductal, Noninfiltrating
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT01185145
2013-07-11
APBI
Rocky Mountain Cancer Centers
Phase 2
Unknown
291 enrolled